HighPoint Advisor Group LLC Makes New $303,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

HighPoint Advisor Group LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 1,120 shares of the company’s stock, valued at approximately $303,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth approximately $25,000. Centerpoint Advisors LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at about $27,000. Atlantic Edge Private Wealth Management LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $27,000. Bruce G. Allen Investments LLC purchased a new position in shares of HCA Healthcare during the fourth quarter worth $28,000. Finally, FinTrust Capital Advisors LLC lifted its holdings in shares of HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after buying an additional 35 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at approximately $10,544,316. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last three months. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

NYSE HCA opened at $338.46 on Friday. The company has a market capitalization of $88.65 billion, a PE ratio of 16.87, a P/E/G ratio of 1.58 and a beta of 1.69. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $343.53. The company has a fifty day moving average of $322.15 and a two-hundred day moving average of $314.80.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. HCA Healthcare’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same period last year, the firm posted $4.93 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.78%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analysts Set New Price Targets

HCA has been the topic of several research reports. TD Cowen decreased their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Barclays boosted their target price on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research report on Monday, April 29th. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, June 16th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $325.59.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.